PEOPLE - Maelor (UK) makes appointment:
This article was originally published in Clinica
Drug delivery and pharmaceutical products company Maelor (Wrexham, UK) has appointed Stephen Appelbee as CEO. Mr Appelbee, who has over 20 years of experience in the pharmaceutical industry, most recently served as senior director of European operations at Maxim Pharmaceuticals.
You may also be interested in...
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.
South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and aims to file a US NDA for the orphan drug.
VMS businesses are deemed essential in Department of Homeland Security guidance that provides as basis for orders by most states and localities across the US. During an AHPA webinar, attorney Trent Norris says the federal government prefers leaving business exemptions to shut-down decisions to the states.